Do you want to generate hundreds of thousands in recurring revenue while working just 4 hours a week—from anywhere in the world?
Do you want to own a business that an ordinary person can operate without a technical degree or specialized expertise?
Do you want to operate without the headache of managing a large team?
Do you want to own novel technology IP and the commercial rights outright, with the freedom to license it across multiple industries?
Do you want to reach customers worldwide rather than being limited to one geographic market?
If your answer is yes, this may be the acquisition opportunity you've been looking for.
**Acquire. License. Scale.**
**Novel AI Digital Twin Technology / Software**
Acquire proprietary AI Digital Twin longevity technology. Own the IP outright. Deploy it across multiple industries and generate recurring revenue through B2B licensing.
License the platform to longevity clinics, longevity companies, physicians, laboratories, and health platforms that need AI Digital Twin capabilities. Each licensee pays recurring fees.
**The platform includes:**
· Proprietary AI Digital Twin platform and novel computational architecture
· Production-ready deployment software
The technology can be deployed across pharmaceutical companies, insurance companies, hospitals, digital health platforms, longevity clinics, and longevity companies.
The buyer acquires the technology once and owns it outright. B2B licensing allows the buyer to license it to multiple businesses and generate recurring revenue from each licensee.
The current monetization is B2C. If you are hiring a doctor for a 1-hour consultation per month, you can utilize the current monetization for a $45,000 annual subscription per customer.
**Revenue model options:**
· B2B deployment licensing fees
· B2C annual subscriptions
· Per-patient or per-transaction fees
· Tiered licensing
· Hybrid models
The buyer's margin is over 90% because the marginal cost of serving the next customer is nearly zero.
**Scale example:** 50 customers at $50K/month = $2.5M monthly recurring revenue. 100 customers = $5M monthly.
**What transfers:**
· Full IP ownership
· Deployment rights across industries
· Proprietary biomedical datasets and knowledge graphs
· Production-ready platform and infrastructure
· Complete commercial rights
**Deal structure:** Asset sale transferring complete ownership and commercial rights.
**Why acquire instead of build:**
· Proprietary datasets took years to assemble
· Novel AI architecture requires specialized expertise
· Specialized talent is rare and expensive
· Regulatory pathway navigation adds years
· Market validation has already been proven through existing implementations
Acquiring it is faster, cheaper, and can generate thousands of dollars in revenue from home.
